Genmab A/S ADR (GMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GMAB | INCY | BMRN | ||
| Company | Genmab A/S ADR | Incyte Corp | Biomarin Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 21.94 | 80.80 | 66.18 | ||
| High | 22.20 | 81.70 | 67.00 | ||
| Low | 21.59 | 80.37 | 66.00 | ||
| Last | 21.66 | 80.48 | 66.66 | ||
| Change | -0.81 | -0.10 | +0.53 | ||
| % Change | -3.60% | -0.12% | +0.80% | ||
| Volume | 2,583,700 | 1,573,200 | 1,455,000 | ||
| 20-Day Average Volume | 1,483,755 | 1,989,100 | 1,507,135 | ||
| Previous Close | 22.47 | 80.58 | 66.13 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 22.76 | 73.25 | 68.05 | ||
| 20-Day Raw Stochastic | 3.72% | 82.07% | 23.27% | ||
| 20-Day Relative Strength | 33.49% | 71.41% | 36.30% | ||
| Weighted Alpha | -36.38 | +56.93 | -29.00 | ||
| Today's Opinion | 100% Sell | 100% Buy | 100% Sell | ||
| Previous Opinion | 100% Sell | 100% Buy | 100% Sell | ||
| Last Month's Opinion | 100% Sell | 100% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.00% since 11/06/24 | -0.58% since 11/06/24 | +0.77% since 11/06/24 | ||
| Low | 21.59 on 11/13/24 | 79.53 on 11/07/24 | 65.75 on 11/07/24 | ||
| High | 23.47 on 11/11/24 | 83.95 on 11/08/24 | 67.95 on 11/11/24 | ||
| 1-Month | |||||
| %Chg | -7.95% since 10/11/24 | +21.72% since 10/11/24 | -5.25% since 10/11/24 | ||
| Low | 21.59 on 11/13/24 | 64.60 on 10/22/24 | 65.35 on 10/31/24 | ||
| High | 23.67 on 10/14/24 | 83.95 on 11/08/24 | 70.98 on 10/25/24 | ||
| 3-Month | |||||
| %Chg | -18.48% since 08/13/24 | +29.76% since 08/13/24 | -26.74% since 08/13/24 | ||
| Low | 21.59 on 11/13/24 | 60.99 on 08/14/24 | 65.35 on 10/31/24 | ||
| High | 27.94 on 08/27/24 | 83.95 on 11/08/24 | 94.85 on 08/20/24 | ||
| 6-Month | |||||
| %Chg | -25.72% since 05/13/24 | +39.72% since 05/13/24 | -17.19% since 05/13/24 | ||
| Low | 21.59 on 11/13/24 | 56.37 on 05/16/24 | 65.35 on 10/31/24 | ||
| High | 30.41 on 05/15/24 | 83.95 on 11/08/24 | 94.85 on 08/20/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 14,869,926 | 15,523,736 | 12,603,252 | ||
| Shares Outstanding, K | 661,768 | 192,650 | 190,583 | ||
| Annual Sales | 2,392,030,000 | 3,695,650,000 | 2,419,230,000 | ||
| Annual Net Income | 631,910,000 | 597,600,000 | 167,650,000 | ||
| Last Quarter Sales | 816,600,000 | 1,137,870,000 | 745,740,000 | ||
| Last Quarter Net Income | 186,610,000 | 106,460,000 | 106,080,000 | ||
| 60-Month Beta | 0.99 | 0.71 | 0.31 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.29 on 11/06/24 | 1.07 on 10/29/24 | 0.91 on 10/29/24 | ||
| Latest Earnings Date | 11/06/24 | 10/29/24 | 10/29/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 22.52 | 0.00 | 29.37 | ||